"drug-firm"

Consolidated revenue from operations of the company stood at Rs 799 crore for the quarter under consideration

The company had posted a net profit of Rs 186.69 crore for the corresponding period of the previous fiscal, Abbott India said in a filing to BSE.

The company had posted a net profit of Rs 359.09 crore for the corresponding period of the previous fiscal

Lupin said it does not believe that the observations will have an impact on disruption of supplies or the existing revenues from operations of this facility

The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad, it added. Dapagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control

AuroLife Pharma, a wholly-owned step-down subsidiary of the company, has received a warning letter from the United States Food and Drug Administration (USFDA) for its oral solid manufacturing facility situated at Dayton

The company has received final approval from the US Food and Drug Administration (USFDA) for the medication in 300 mg strength, Zydus Cadila said in a statement